Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

Dysregulated microRNAs affect pathways and targets of biologic relevance in nasal-type natural killer/T-cell lymphoma.

Ng SB, Yan J, Huang G, Selvarajan V, Tay JL, Lin B, Bi C, Tan J, Kwong YL, Shimizu N, Aozasa K, Chng WJ.

Blood. 2011 Nov 3;118(18):4919-29. doi: 10.1182/blood-2011-07-364224. Epub 2011 Sep 14. Erratum in: Blood. 2014 Jan 9;123(2):302.

2.

microRNA profiling in Epstein-Barr virus-associated B-cell lymphoma.

Imig J, Motsch N, Zhu JY, Barth S, Okoniewski M, Reineke T, Tinguely M, Faggioni A, Trivedi P, Meister G, Renner C, Grässer FA.

Nucleic Acids Res. 2011 Mar;39(5):1880-93. doi: 10.1093/nar/gkq1043. Epub 2010 Nov 9.

3.

Update on the World Health Organization classification of peripheral T-cell lymphomas.

O'Leary HM, Savage KJ.

Curr Hematol Malig Rep. 2009 Oct;4(4):227-35. doi: 10.1007/s11899-009-0030-5. Review.

PMID:
20425412
4.

Identification of an NK/T cell-restricted progenitor in adult bone marrow contributing to bone marrow- and thymic-dependent NK cells.

Nozad Charoudeh H, Tang Y, Cheng M, Cilio CM, Jacobsen SE, Sitnicka E.

Blood. 2010 Jul 15;116(2):183-92. doi: 10.1182/blood-2009-10-247130. Epub 2010 Apr 26.

5.

The microRNA profile of prostate carcinoma obtained by deep sequencing.

Szczyrba J, Löprich E, Wach S, Jung V, Unteregger G, Barth S, Grobholz R, Wieland W, Stöhr R, Hartmann A, Wullich B, Grässer F.

Mol Cancer Res. 2010 Apr;8(4):529-38. doi: 10.1158/1541-7786.MCR-09-0443. Epub 2010 Mar 30.

6.

Estrogen receptor alpha controls a gene network in luminal-like breast cancer cells comprising multiple transcription factors and microRNAs.

Cicatiello L, Mutarelli M, Grober OM, Paris O, Ferraro L, Ravo M, Tarallo R, Luo S, Schroth GP, Seifert M, Zinser C, Chiusano ML, Traini A, De Bortoli M, Weisz A.

Am J Pathol. 2010 May;176(5):2113-30. doi: 10.2353/ajpath.2010.090837. Epub 2010 Mar 26.

7.

MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor.

Tie J, Pan Y, Zhao L, Wu K, Liu J, Sun S, Guo X, Wang B, Gang Y, Zhang Y, Li Q, Qiao T, Zhao Q, Nie Y, Fan D.

PLoS Genet. 2010 Mar 12;6(3):e1000879. doi: 10.1371/journal.pgen.1000879.

8.

Characterization of the Melanoma miRNAome by Deep Sequencing.

Stark MS, Tyagi S, Nancarrow DJ, Boyle GM, Cook AL, Whiteman DC, Parsons PG, Schmidt C, Sturm RA, Hayward NK.

PLoS One. 2010 Mar 12;5(3):e9685. doi: 10.1371/journal.pone.0009685.

9.

ZEB1 and CtBP form a repressive complex at a distal promoter element of the BCL6 locus.

Papadopoulou V, Postigo A, Sánchez-Tilló E, Porter AC, Wagner SD.

Biochem J. 2010 Apr 14;427(3):541-50. doi: 10.1042/BJ20091578.

PMID:
20175752
10.

miR-449 regulates CDK-Rb-E2F1 through an auto-regulatory feedback circuit.

Feng M, Yu Q.

Cell Cycle. 2010 Jan 15;9(2):213-4. Epub 2010 Jan 2. No abstract available.

PMID:
20046097
11.

MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1.

Sachdeva M, Mo YY.

Cancer Res. 2010 Jan 1;70(1):378-87. doi: 10.1158/0008-5472.CAN-09-2021. Epub 2009 Dec 8.

12.

Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type.

Huang Y, de Reyniès A, de Leval L, Ghazi B, Martin-Garcia N, Travert M, Bosq J, Brière J, Petit B, Thomas E, Coppo P, Marafioti T, Emile JF, Delfau-Larue MH, Schmitt C, Gaulard P.

Blood. 2010 Feb 11;115(6):1226-37. doi: 10.1182/blood-2009-05-221275. Epub 2009 Nov 30.

13.

Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer.

Gao C, Zhang Z, Liu W, Xiao S, Gu W, Lu H.

Cancer. 2010 Jan 1;116(1):41-9. doi: 10.1002/cncr.24743.

14.

Expression and processing of a small nucleolar RNA from the Epstein-Barr virus genome.

Hutzinger R, Feederle R, Mrazek J, Schiefermeier N, Balwierz PJ, Zavolan M, Polacek N, Delecluse HJ, Hüttenhofer A.

PLoS Pathog. 2009 Aug;5(8):e1000547. doi: 10.1371/journal.ppat.1000547. Epub 2009 Aug 14.

15.

Nasal natural killer (NK)/T-cell lymphoma: clinical, histological, virological, and genetic features.

Harabuchi Y, Takahara M, Kishibe K, Moriai S, Nagato T, Ishii H.

Int J Clin Oncol. 2009 Jun;14(3):181-90. doi: 10.1007/s10147-009-0882-7. Epub 2009 Jul 11. Review.

PMID:
19593607
16.

SnapShot: MicroRNAs in Cancer.

Spizzo R, Nicoloso MS, Croce CM, Calin GA.

Cell. 2009 May 1;137(3):586-586.e1. doi: 10.1016/j.cell.2009.04.040. No abstract available.

17.

MicroRNA signature of primary pigmented nodular adrenocortical disease: clinical correlations and regulation of Wnt signaling.

Iliopoulos D, Bimpaki EI, Nesterova M, Stratakis CA.

Cancer Res. 2009 Apr 15;69(8):3278-82. doi: 10.1158/0008-5472.CAN-09-0155. Epub 2009 Apr 7.

18.

Identification of novel Epstein-Barr virus microRNA genes from nasopharyngeal carcinomas.

Zhu JY, Pfuhl T, Motsch N, Barth S, Nicholls J, Grässer F, Meister G.

J Virol. 2009 Apr;83(7):3333-41. doi: 10.1128/JVI.01689-08. Epub 2009 Jan 14.

19.

miR-142-3p restricts cAMP production in CD4+CD25- T cells and CD4+CD25+ TREG cells by targeting AC9 mRNA.

Huang B, Zhao J, Lei Z, Shen S, Li D, Shen GX, Zhang GM, Feng ZH.

EMBO Rep. 2009 Feb;10(2):180-5. doi: 10.1038/embor.2008.224. Epub 2008 Dec 19.

20.

Comprehensive profiling of Epstein-Barr virus microRNAs in nasopharyngeal carcinoma.

Cosmopoulos K, Pegtel M, Hawkins J, Moffett H, Novina C, Middeldorp J, Thorley-Lawson DA.

J Virol. 2009 Mar;83(5):2357-67. doi: 10.1128/JVI.02104-08. Epub 2008 Dec 17.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk